Trials / Unknown
UnknownNCT01273012
Cost-effectiveness of Infloran (TM) in Treating Acute Childhood Diarrhea in Phramongkutklao Hospital
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 128 (estimated)
- Sponsor
- Phramongkutklao College of Medicine and Hospital · Academic / Other
- Sex
- All
- Age
- 3 Months – 6 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether the probiotic Infloran is cost-effective in treating acute childhood diarrhea.
Detailed description
Probiotics have been proved to shorten duration of diarrhea in children; whether they are cost-effective is less clear. We'd like to validate the use of Infloran, a proprietary probiotic sold in Thailand, in terms of its cost-effectiveness compared to standard diarrhea care in our hospital setting.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Probiotic - Infloran | Drug:Probiotic - Infloran (TM) 1 cap (1 billion CFU of L. acidophilus and 1 billion CFU of B. bifidum) PO bid or tid |
Timeline
- Start date
- 2010-04-01
- Primary completion
- 2011-08-01
- Completion
- 2011-12-01
- First posted
- 2011-01-10
- Last updated
- 2011-08-01
Locations
1 site across 1 country: Thailand
Source: ClinicalTrials.gov record NCT01273012. Inclusion in this directory is not an endorsement.